Blood flow surveillance of hemodialysis grafts: insights from two case reports

Access Monitoring Does Not Really Improve Outcomes

It is widely accepted that hemodialysis access monitoring combined with preemptive percutaneous transluminal angioplasty (PTA) improves outcomes. The many studies that have evaluated monitoring during the last decade provide an opportunity to examine whether this hypothesis is valid. Because synthetic grafts are more likely than autogenous arteriovenous fistulas to benefit from monitoring, this review is restricted to grafts. Recent studies show that monitoring does not accurately predict graft thrombosis or failure, nor does it prolong graft life. However, monitoring can reduce thrombosis, and thereby reduce access-related hospitalizations and use of central venous dialysis catheters. Because preemptive PTA is expensive, however, monitoring does not reduce the cost of access-related care. The limited benefit that monitoring provides emphasizes the urgent need to develop better approaches to solving the problem of graft thrombosis and failure.

Assessment of Stenosis in Vascular Access Grafts

The major complication that occurs with grafts used as vascular access for hemodialysis, is stenosis at the venous anastomosis or in the draining vein. 75% area stenosis is considered significant as thrombotic occlusion may occur. The aim of this experimental study was to evaluate invasive and noninvasive indices to detect significant stenoses in a vascular access graft. A compliant underarm loop graft in vitro model was built and studied with 50, 65, 80, and 90% stenosis at flow rates of 500, 1000, and 1500 mL/min. Flow in the system was pulsatile. Velocity was measured with ultrasound Doppler and the pressure was measured invasively. The resistance index (RI), p(venous line)/MAP, and the newly introduced pressure ratio (PR) were calculated and compared. A stenosis can be suspected when a high frequency ultrasound velocity signal develops at the venous anastomosis. RI > 1 confirms a very severe stenosis (90%). The parameter PR < 8% confirms significant stenoses showing its clinical relevancy.

Access flow measurement during surveillance and percutaneous transluminal angioplasty intervention

The introduction of routine access flow measurement methodology has enabled accurate identification of problematic accesses and provided a means for follow-up evaluation. These methods have uncovered, in some cases, that interventions are either immediately unsuccessful or that they fail within 3 months to maintain flow above preintervention levels. The purpose of this article is to analyze the main problems that occur at each step in the loop of flow surveillance-intervention-follow-up and to provide suggestions for improving outcomes. Analysis of published access flow data suggests that the main problems lie in the areas of inadequate analysis of flow surveillance data, lack of objective technology for quantifying intervention effectiveness, and lack of follow-up flow measurements in the hemodialysis (HD) unit after the intervention. The following three recommendations may improve surveillance outcomes: 1). using a reliable access flow technology combined with analysis of all hemodynamic data (including mean arterial pressure) before referring patients for angiography to decrease surveillance false positives; 2). performing intra-access blood flow measurement during angioplasty, which may improve outcomes by giving warning of errors before the patient leaves the intervention suite. Success achieved in restoring flow as measured during the intervention usually predicts good immediate outcomes in the HD unit; 3). measuring access flows during the next week after angioplasty. If the results are unsatisfactory, the patient should be further evaluated to avoid a potential thrombotic event.